logo

For the Inventor, By the Inventor

Kisarazu, Japan

Reverse Proteomics Research Institute


USPTO Granted Patents = 13

% Expired Patents = 76.9

Forward Citations = 2

Loading Chart...
Loading Chart...

24 inventors (with patents filed for the assignee):

goldMedal Akito Tanaka (7 out of 22 patents)

silverMedal Akira Yamazaki (6 out of 6 patents)

bronzeMedal Takeshi Tsutsumi (4 out of 4 patents)

4.  Yorimasa Suwa (4 out of 10 patents)

5.  Tomohiro Terada (3 out of 23 patents)

6.  Tadakazu Yamauchi (3 out of 3 patents)

7.  Morikazu Kito (3 out of 16 patents)

8.  Masayuki Haramura (3 out of 3 patents)

9.  Takaaki Shiyama (2 out of 2 patents)

10.  Junichi Yamamoto (2 out of 2 patents)

11.  Hideaki Sueoka (2 out of 2 patents)

12.  Kouichi Tsuchiya (2 out of 2 patents)

13.  Katsuhisa Murayama (2 out of 2 patents)

14.  Kazuo Komiya (2 out of 2 patents)

15.  Yuko Isono (2 out of 2 patents)


13 patents:

1. 8778613 - Affinity resin (2014-07-15),
2. 8309687 - Biomarker specific for cancer (2012-11-13),
3. 8178077 - Drug development target protein and target gene, and method of screening (2012-05-15),
4. 8153764 - Biomarker specific to brain/nerve or specific to neuronal differentiation (2012-04-10),
5. 8153385 - Target protein and target gene in drug designing and screening method (2012-04-10),
6. 8058009 - Target protein and target gene in drug designing and screening method (2011-11-15),
7. 7923211 - Method of calibrating ligand specificity (2011-04-12),
8. 7919653 - Method of inhibiting nonspecific interaction between molecules on solid phase support (2011-04-05),
9. 7754497 - Method for immobilizing proteins (2010-07-13),
10. 7659426 - Target protein of anticancer agent and novel anticancer agent (spnal) corresponding thereto (2010-02-09),
11. 7645614 - Method of immobilizing compound on solid phase support (2010-01-12),
12. 7592187 - Method of calibrating ligand specificity (2009-09-22),
13. 7456022 - Solid support having ligand immobilized thereon by using photocleavable linker (2008-11-25),
Company Overview
Reverse Proteomics Research Institute, located in Kisarazu, Japan, specializes in the innovative field of reverse proteomics, focusing on the analysis and interpretation of protein functions and interactions. The institute aims to advance understanding of complex biological systems through cutting-edge research and technology development. By leveraging advanced computational methods and experimental techniques, it contributes to various applications in drug discovery, disease diagnosis, and therapeutic development, fostering collaboration within the scientific community.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#1 in Kisarazu

#3,749 in Japan

#45,039 in the World

Kisarazu, JP
Kisarazu, Japan

Reverse Proteomics Research Institute

Forward Citations = 2

24 inventors:

goldMedal Akito Tanaka (7 out of 22 patents)

silverMedal Akira Yamazaki (6 out of 6 patents)

bronzeMedal Takeshi Tsutsumi (4 out of 4 patents)

4.  Yorimasa Suwa (4 out of 10 patents)

5.  Tomohiro Terada (3 out of 23 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Reverse Proteomics Research Institute. Retrieved from https://idiyas.com/company/reverse-proteomics-research-institute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…